MedTrace Logo

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

NCT03898310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2023-06-13

No results posted yet for this study

Summary

The risk of urinary tract infection (UTI) following female incontinence surgery ranges between 6-48%. The literature has shown mixed results of the therapeutic efficacy of cranberry extract to prevent UTI in females, with some promising preliminary work in the prevention of UTI's following gynecologic surgery. The researchers will conduct a study of the effect of cranberry extracts on preventing urinary tract infections following mid urethral slings, which are the most common urinary incontinence procedures.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cranberry extract capsules

Participants in the treatment arm will receive cranberry extract capsules.

DIETARY_SUPPLEMENT

Placebo capsule

Participants in the placebo arm will receive placebo capsules.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Lieschen Quiroz, MD · University of Oklahoma

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-05
Primary Completion
2023-01-22
Completion
2023-01-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03898310 on ClinicalTrials.gov